Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-10.28
Price to sales ratio
473.62

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1202
DNTH
Dianthus Therapeutics, Inc. - Common Stock
111.54 USD+0.70%+1.00%+9.22%+350.85%6.24 B USD
1209
BLTE
Belite Bio Inc - American Depositary Shares
157.01 USD+0.20%-3.97%+2.48%+146.10%6.18 B USD
1229
PTCT
PTC Therapeutics, Inc. - Common Stock
71.81 USD-1.21%+1.80%-4.06%+44.14%5.99 B USD
1245
DFTX
Definium Therapeutics, Inc. - Common Shares
43.82 USD+0.11%-4.51%+4.33%+190.01%5.89 B USD

Frequently asked questions about Xenon Pharmaceuticals Inc

What is the Xenon Pharmaceuticals Inc stock price today?

The current price of Xenon Pharmaceuticals Inc (XENE) is 61.93. Over the past 24 hours, the stock has changed by -2.92%. Follow the XENE chart for real-time price dynamics.

What is the stock ticker of Xenon Pharmaceuticals Inc?

Xenon Pharmaceuticals Inc trades under the ticker XENE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Xenon Pharmaceuticals Inc stock going up?

XENE has changed by +2.45% over the last week, -5.19% over the last month, and +51.83% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Xenon Pharmaceuticals Inc?

Xenon Pharmaceuticals Inc currently has a market capitalization of 6 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Xenon Pharmaceuticals Inc earnings last quarter?

Last quarter, Xenon Pharmaceuticals Inc reported earnings of -1.11 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Xenon Pharmaceuticals Inc revenue for the last quarter?

Xenon Pharmaceuticals Inc reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Xenon Pharmaceuticals Inc net income for the last quarter?

Xenon Pharmaceuticals Inc reported net income of -110.74 M for the last quarter. The previous quarter showed -102.3 M, which means net income changed by -8.24%.

How many employees does Xenon Pharmaceuticals Inc have?

As of the latest available data, Xenon Pharmaceuticals Inc has 370 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Xenon Pharmaceuticals Inc stock?

You can buy Xenon Pharmaceuticals Inc (XENE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Xenon Pharmaceuticals Inc stock?

Investing in Xenon Pharmaceuticals Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the XENE chart and related analysis on metatrader.com as part of your research.

News